GOAL 2050 - goal2050
Normax will participate as a strategic partner in the global ecosystem for transformative research, development and manufacture of safe and effective mRNA vaccines for global public health and pandemic preparedness and prevention, with competitive financial performance. We plan to deliver safe and effective mRNA vaccines at large scale for about $4 dollars a dose.
With mRNA vaccine technology, Normax aims to be a trusted guide for your journey to health and happiness and competitive financial returns via Normax financial mRNA vaccine products to suit most any risk/return appetite. Normax can help with the diseases that are important to you and your customers and generate competitive returns with powerful social impact. Normax has engaged a global team of experts and companies to deliver on the mission for our customers.
Normax will do mRNA vaccine research and development using its own mRNA UCV Consortium, and mRNA vaccine manufacturing by building Vax factories all over the world.
GOAL 2050 - goal2050